| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.45B | +2.5% |
| R&D Expense | $32.0M | +3.2% |
| SG&A Expense | $204.0M | -10.1% |
| Interest Expense | $106.0M | -45.6% |
| Pre-tax Income | $702.0M | -41.5% |
| Income Tax | $664.0M | +5.6% |
| Net Income | -$123.0M | -128.7% |
| EPS (Basic) | -$0.68 | -129.6% |
| EPS (Diluted) | -$0.68 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.36B | -24.9% |
| Accounts Receivable | $778.0M | +2.8% |
| Inventory | $2.43B | +24.1% |
| Current Assets | $5.25B | +4.5% |
| Total Assets | $14.76B | -1.8% |
| Current Liabilities | $3.00B | -6.8% |
| Long-term Debt | $1.81B | +4.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $822.0M | -10.7% |
| Capital Expenditures | $480.0M | +23.1% |
| Investing Cash Flow | -$495.0M | -187.6% |
| Financing Cash Flow | -$768.0M | +33.7% |
| Free Cash Flow | $342.0M | -35.5% |
| -130.1% |
| Total Liabilities |
| $8.17B |
| -6.6% |
| Stockholders' Equity | $5.08B | +8.6% |